BioSpace News Archive

Cardiac Insight, Inc. (“Cardiac Insight” or the “Company”) is a healthcare innovator specializing in wearable cardiac sensors and proprietary software that automatically analyzes electrocardiogram (ECG) data to improve early detection and diagnosis of cardiac arrythmias, such as atrial fibrillation (AFib).

InMed Pharmaceuticals Inc., a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates as well as manufacturing technologies for pharmaceutical-grade rare cannabinoids, announced that Eric. A. Adams, President and CEO of InMed will present live at LifeSciencesInvestorForum.com on June 24th.

The market is anticipated to grow with a CAGR of 5.6% from 2020-2027.

The market growth is attributed to the escalating cardiovascular disease prevalence, increasing neurovascular disease incidence, and rising elderly population.

The temperature management systems market is projected to reach US$ 3,343.41 million by 2028 from US$ 2,332.93 million in 2021; it is expected to grow at a CAGR of 5.3% from 2021 to 2028.

Micro-Tech Endoscopy recently expanded its EMR and ESD portfolio with the launch of its BlueBoost submucosal lift.

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced a broad multi-year Cooperative Research and Development Agreement (CRADA) with NAMRU-3.

Zealand Pharma A/S today announced that members of its senior management team are scheduled to participate virtually in the LifeSci Nordic Biotech Summit.

BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, announced that it has commenced an underwritten public offering of $100.0 million of shares of its common stock.

Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2021 on Thursday, July 22, 2021 beginning at 8:00 a.m. ET and lasting approximately 1 hour.